Respiratory Inhalers Market By Type (Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers), By Application (Asthma, Chronic Obstructive Pulmonary Disorder, Pulmonary Arterial Hypertension, Cystic Fibrosis), By Technology (Digital, Manual) - Growth, Future Prospects & Competitive Analysis, 2017 – 2025

Respiratory inhalers are used to administer an extensive range of medications such as beta-agonists, anticholinergic, corticosteroids and certain antibiotics. Respiratory inhalers are used to provide relief of symptoms in various respiratory conditions such as asthma, chronic obstructive pulmonary disorder (COPD), pulmonary arterial hypertension, bronchitis and cystic fibrosis. In such respiratory conditions both mild and severe symptoms occur such as coughing, shortness of breath, chest congestion, respiratory discomfort and even death in extreme cases. Thus it becomes important to relieve the symptoms immediately which is accomplished by the use of inhalers.

Drug administration by inhalers is most widely prescribed as it requires lesser doses to give quick relief thus reducing the risk of side effects unlike oral medications. The rise in prevalence of the aforementioned respiratory conditions and the continuous rise in environmental pollution has led to the rise in growth of respiratory inhaler market in the current and forecast period, 2017-2025.

The current study report on respiratory inhalers provides an in depth insight on the market trends and dynamics. The report includes market estimations and forecast data for the period 2017-2025. The market has been analyzed and studied into various segments which are as follows:

  • Type
    • Dry powder Inhalers
    • Metered Dose Inhalers
      • Pressurized
      • Breath-actuated
      • Non-pressurized
    • Nebulizers
      • Jet nebulizer
      • Mesh nebulizer
      • Ultrasonic nebulizer
  • Application
    • Asthma
    • Chronic Obstructive Pulmonary Disorder
    • Pulmonary Arterial Hypertension
    • Cystic Fibrosis
    • Others
  • Technology
    • Digital
    • Manual

The respiratory inhalers market have also been studied across geographies. For the purpose of this study the respiratory inhalers market is segmented based on geographies as follows:

  • North America
    • USA
    • Canada
  • Europe
    • U.K
    • Germany
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

Market evaluation and forecast analysis for the above mentioned segments for the duration 2015-2025 has been incorporated in this report. The values are have been represented in terms of US$ Mn. Furthermore, the respective growth rates for each of the mentioned segments has also been inculcated with 2016 as the base year.

This report also comprehends qualitative insights with respect to market restraints, opportunities and drivers. These insights provides an overview of the entire market and would assist emerging players to strategize their product growth within this market. A competitive landscape depicting market position of the industrial players has also been incorporated win this report. Company profiles of each of the industrial leaders with respect to financial performance, product portfolio, current market trends and general information has been incorporated. The profiles of major industrial leaders incorporated are Boehringer Ingelheim GmbH, Astra Zeneca, PARI Medical Holding, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Cipla Inc., GlaxoSmithKline plc, Beximco Pharmaceuticals Ltd., Sandoz, Baxter International, OMRON Healthcare Europe B.V, Propeller Health, Adherium and others.

Respiratory Inhalers Market

Based on technology, the global respiratory inhalers market is segmented as follows:

  • Digital
  • Manual

Manual respiratory inhalers currently dominate the market as it is widely available and affordable across geographies. The digital segment is expected to grow in the forecast period owing to the emergence of smart inhalers into the market. Digital inhalers enable the recovery of real time data which could be recovered at any point of time. For example Adherium’s smart touch inhaler integrated with bluetooth facility has entered the market along with AstraZeneca’s drug Symbicort aerosol inhaler. Moreover, the collaboration of Propeller Health and Novartis to develop a dry powder inhaler has also contributed to the growth of this market. The device comprises of an add-on sensor that would provide dosage data which can be easily monitored would provide better patient adherence and would help enable remote monitoring of patients. These advancements are creating demand for the respiratory inhalers, increasing patient adherence and thus the digital segment is projected to show remunerative growth during the forecast period, 2017-2025. Furthermore, the development of a structured digital reimbursement policy for chronic conditions is expected to propel the demand for smart inhalers in the future.

Respiratory Inhalers Market

For the purpose of this study, the global respiratory inhalers market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Respiratory Inhalers Market

The respiratory inhalers have a vast outreach and is available across all geographies. North America held the leading position in the respiratory inhalers market. The availability of respiratory inhalers, presence of leading industries in this region, higher economic status of patients and constant development of digital health reimbursement policy are the catalysts that drive this market. The Centers for Medicare and Medicaid Services (CMS) is providing various solutions to organizations to provide reimbursement options for managing chronic conditions with non-face-to-face monitoring patients such as asthma and COPD. Asia Pacific is expected to be the fastest growing market for respiratory inhalers owing to a high prevalence of respiratory conditions such as asthma and COPD. The World Health Organization (WHO) states that 80% of deaths occur in the low and middle income economies. The constant rise in industrialization leading to increase in pollution has also increased the risk of acquiring respiratory diseases thus having a positive impact on the respiratory inhaler market in Asia Pacific during the forecast period, 2017-2025.

Choose License Type
Related Report










Published Date:  Nov 2017
Category:  Medical Devices
Report ID:   58860
Report Format:   PDF
Pages:   120
Rating:    4.3 (40)
Connect With Us
+1-408-641-3282
24/7 Research Support